City of Hope

www.cityofhope.org

 

Hematologic Malignancies
07:37

Insights from 2025 Tandem Annual Meeting

Tandem 2025 Insights: PTCy-Based GVHD Prophylaxis After Mismatched Unrelated Donor Peripheral Blood SCT Using Myeloablative Conditioning - Results From the ACCESS Trial

FEATURING Monzr Al Malki
  • 140 views
  • February 21, 2025
  • 1
12:13

City of Hope

Sequencing T-Cell Therapies in Relapsed Myeloma: BCMA, Bispecifics, and Resistance

FEATURING Amrita Krishnan
  • 76 views
  • November 21, 2024
09:42

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based GvHD Prophylaxis Following Mismatched Unrelated Donor PBSC Transplantation"

FEATURING Monzr Al Malki
  • 283 views
  • June 7, 2024
  • 3
27:47

City of Hope

Chronic GVHD: Review Advances in Prevention, Novel Endpoints, and Targeted Strategies

FEATURING Idoroenyi Amanam
  • 221 views
  • March 11, 2024
  • 1
08:46

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Updated Results From XPORT-MF-034 - Selinexor + Ruxolitinib in JAKi Treatment-Naïve Patients With Myelofibrosis"

FEATURING Haris Ali
  • 208 views
  • June 14, 2023
  • 1
16:27

City of Hope

Transplant Optimization in Older Adults With Hematologic Malignancies: How Old Is Too Old?

FEATURING Andrew Artz
  • 22 views
  • June 29, 2021
  • 1